Pluronic F127-based systemic vaccine delivery systems

Area of Science:

• Biomaterials Science
• Immunology
• Vaccine Development

Background:

• Non-ionic block copolymers like Pluronic F127 (F127) exhibit reverse thermogelation, transitioning from liquid to gel at physiological temperatures.
• This property makes F127 a potential matrix for controlled vaccine delivery.

Purpose of the Study:

• To evaluate F127-based vaccine delivery systems combined with immunomodulators (CpG motifs, chitosan).
• To compare the efficacy of these novel systems against traditional adjuvants using protein antigens (tetanus toxoid, diphtheria toxoid, anthrax recombinant protective antigen).

Main Methods:

• Formulation of protein antigens with F127 and immunomodulators (CpG, chitosan).
• Administration of formulations to mice and measurement of IgG antibody responses.
• Assessment of antibody functional activity via in vivo tetanus toxin challenge and anthrax lethal toxin neutralization assays.

Main Results:

• F127/CpG and F127/chitosan combinations significantly enhanced IgG antibody responses compared to antigens with immunomodulators alone.
• These novel formulations elicited significantly greater responses than aluminum salt adjuvants.
• Demonstrated functional activity of antibodies generated by the F127-based systems.

Conclusions:

• Block-copolymer (F127) based vaccine delivery systems combined with immunomodulators effectively enhance antigen-specific antibody responses.
• This approach shows promise for improving various vaccination strategies.
• The F127 system offers a viable alternative to traditional vaccine adjuvants.